scholarly journals Conservative management in elderly patients with advanced chronic kidney disease

2020 ◽  
Author(s):  
M.V. Rubio Rubio
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Elderly Patients ◽  
Conservative Management ◽  
Advanced Chronic Kidney Disease

scholarly journals Treatment plans and outcomes in elderly patients reaching advanced chronic kidney disease

2018 ◽  
Vol 33 (12) ◽  
pp. 2182-2191 ◽  
Author(s):  
Olivier Moranne ◽  
Coraline Fafin ◽  
Sophie Roche ◽  
Maud Francois ◽  
Vincent Allot ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Elderly Patients ◽  
Advanced Chronic Kidney Disease ◽  
Treatment Plans

Dialysis Therapy and Conservative Management of Advanced Chronic Kidney Disease in the Elderly: A Systematic Review

Nephron ◽  
2017 ◽  
Vol 137 (3) ◽  
pp. 178-189 ◽  
Author(s):  
Supakanya Wongrakpanich ◽  
Paweena Susantitaphong ◽  
Suramath Isaranuwatchai ◽  
Jirat Chenbhanich ◽  
Somchai Eiam-Ong ◽  
...  
Keyword(s):  
Systematic Review ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Conservative Management ◽  
The Elderly ◽  
Dialysis Therapy ◽  
Advanced Chronic Kidney Disease

scholarly journals The association of beta-blocker use with mortality in elderly patients with congestive heart failure and advanced chronic kidney disease

2019 ◽  
Vol 35 (5) ◽  
pp. 782-789 ◽  
Author(s):  
Amber O Molnar ◽  
William Petrcich ◽  
Matthew A Weir ◽  
Amit X Garg ◽  
Michael Walsh ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Kidney Disease ◽  
Congestive Heart Failure ◽  
Kidney Disease ◽  
Elderly Patients ◽  
Randomized Trials ◽  
Advanced Chronic Kidney Disease ◽  
All Cause Mortality ◽  
Β Blocker ◽  
Β Blockers

Abstract Background Whether the survival benefit of β-blockers in congestive heart failure (CHF) from randomized trials extends to patients with advanced chronic kidney disease (CKD) [estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m2 but not receiving dialysis] is uncertain. Methods This was a retrospective cohort study using administrative datasets. Older adults from Ontario, Canada, with incident CHF (median age 79 years) from April 2002 to March 2014 were included. We matched new users of β-blockers to nonusers on age, sex, eGFR categories (>60, 30–60, <30), CHF diagnosis date and a high-dimensional propensity score. Using Cox proportional hazards models, we examined the association of β-blocker use versus nonuse with all-cause mortality. Results We matched 5862 incident β-blocker users (eGFR >60, n = 3136; eGFR 30–60, n = 2368; eGFR <30, n = 358). There were 2361 mortality events during follow-up. β-Blocker use was associated with reduced all-cause mortality [adjusted hazard ratio (HR) 0.58, 95% confidence interval (CI) 0.54–0.64]. This result was consistent across all eGFR categories (>60: adjusted HR 0.55, 95% CI 0.49–0.62; 30–60: adjusted HR 0.63, 95% CI 0.55–0.71; <30: adjusted HR 0.55, 95% CI 0.41–0.73; interaction term, P = 0.30). The results were consistent in an intention-to-treat analysis and with β-blocker use treated as a time-varying exposure. Conclusions β-Blocker use is associated with reduced all-cause mortality in elderly patients with CHF and CKD, including those with an eGFR <30. Randomized trials that examine β-blockers in patients with CHF and advanced CKD are needed.

scholarly journals PTH levels and not serum phosphorus levels are a predictor of the progression of kidney disease in elderly patients with advanced chronic kidney disease

2017 ◽  
Vol 37 (2) ◽  
pp. 149-157
Author(s):  
Néstor Gabriel Toapanta Gaibor ◽  
Nathasha Carolina Nava Pérez ◽  
Yeleine Martínez Echevers ◽  
Rafael Montes Delgado ◽  
María Ángeles Guerrero Riscos
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Elderly Patients ◽  
Serum Phosphorus ◽  
Advanced Chronic Kidney Disease ◽  
Progression Of Kidney Disease ◽  
Phosphorus Levels

scholarly journals FP167RISK STRATIFICATION IS A HELPFUL TOOL IN THE MANAGEMENT OF ELDERLY PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE

2019 ◽  
Vol 34 (Supplement_1) ◽  
Author(s):  
Andra Nastasa ◽  
Mihai Onofriescu ◽  
Dimitrie Siriopol ◽  
Nistor Ionut ◽  
Simona Hogas ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Elderly Patients ◽  
Advanced Chronic Kidney Disease ◽  
Helpful Tool
Sign in / Sign up

Export Citation Format

Share Document